Evidence map›Paper›PMID 26963850›Full record

ArticlePain2016

Epac-protein kinase C alpha signaling in purinergic P2X3R-mediated hyperalgesia after inflammation.

Yanping Gu, Guangwen Li, Yong Chen, Li-Yen Mae Huang

Open access · hybridAbstract read
In one paragraph

Article in Pain, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 48 citations in OpenAlex.

  1. Role of EPAC1 in chronic pain.Biochemistry and biophysics reports · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Regulation of Mitochondrial Function by Epac2 Contributes to Acute Inflammatory Hyperalgesia.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. βBritish journal of pharmacology · 2020
    Article
  14. Article
  15. Effect of PKC/NF-Pain research & management · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yanping GuDepartment of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX, USA.
Guangwen Li
Yong Chen
Li-Yen Mae Huang
The University of Texas Medical Branch at Galveston · US

Funding

NEURON-GLIA INTERACTIONS IN TRIGEMINAL GANGLIA AS A BASIS FOR FUTURE THERAPYR01DE017813 · NIDCR · UNIVERSITY OF TEXAS MED BR GALVESTON · PI HUANG, LI-YEN M · 2006 to 2017
$3.9M
TRIGEMINAL NEURONS--SUSTAINED RESPONSE TO OPOIDSR01NS030045 · NINDS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI HUANG, LI-YEN M · 1993 to 2014
$3.7M
NIDCR NIH HHS R01 DE017813NINDS NIH HHS R01 NS030045
6 · The paper itself

Abstract

Sensitization of purinergic P2X3 receptors (P2X3Rs) is a major mechanism contributing to injury-induced exaggerated pain responses. We showed in a previous study that cyclic adenosine monophosphate (cAMP)-dependent guanine nucleotide exchange factor 1 (Epac1) in rat sensory dorsal root ganglia (DRGs) is upregulated after inflammatory injury, and it plays a critical role in P2X3R sensitization by activating protein kinase C epsilon (PKCε) inside the cells. protein kinase C epsilon has been established as the major PKC isoform mediating injury-induced hyperalgesic responses. On the other hand, the role of PKCα in receptor sensitization was seldom considered. Here, we studied the participation of PKCα in Epac signaling in P2X3R-mediated hyperalgesia. The expression of both Epac1 and Epac2 and the level of cAMP in DRGs are greatly enhanced after complete Freund adjuvant (CFA)-induced inflammation. The expression of phosphorylated PKCα is also upregulated. Complete Freund adjuvant (CFA)-induced P2X3R-mediated hyperalgesia is not only blocked by Epac antagonists but also by the classical PKC isoform inhibitors, Go6976, and PKCα-siRNA. These CFA effects are mimicked by the application of the Epac agonist, 8-(4-chlorophenylthio)-2 -O-methyl-cAMP (CPT), in control rats, further confirming the involvement of Epacs. Because the application of Go6976 prior to CPT still reduces CPT-induced hyperalgesia, PKCα is downstream of Epacs to mediate the enhancement of P2X3R responses in DRGs. The pattern of translocation of PKCα inside DRG neurons in response to CPT or CFA stimulation is distinct from that of PKCε. Thus, in contrast to prevalent view, PKCα also plays an essential role in producing complex inflammation-induced receptor-mediated hyperalgesia.

Indexed as

AnimalsCarbazolesCells, CulturedCyclic AMPEnzyme InhibitorsGanglia, SpinalGuanine Nucleotide Exchange FactorsHyperalgesiaInflammationMaleProtein Kinase C-alphaRatsRats, Sprague-DawleyReceptors, Purinergic P2X3Signal TransductionCarbazolesCyclic AMPEnzyme InhibitorsGo 6976Guanine Nucleotide Exchange FactorsProtein Kinase C-alphaRapgef3 protein, ratReceptors, Purinergic P2X3

Identifiers

PMID26963850
PMCPMC4912236
OpenAlexW2327655421

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.